Andrzejczyk, Karolina
Abou Kamar, Sabrina
van Ommen, Anne-Mar
Canto, Elisa Dal
Petersen, Teun B.
Valstar, Gideon
Akkerhuis, K. Martijn
Cramer, Maarten Jan
Umans, Victor
Rutten, Frans H.
Teske, Arco
Boersma, Eric
Menken, Roxana
van Dalen, Bas M.
Hofstra, Leonard
Verhaar, Marianne
Brugts, Jasper
Asselbergs, Folkert
den Ruijter, Hester
Kardys, Isabella
Funding for this research was provided by:
DCVA RECONNEXT
EU/EFPIA Innovative Medicines Initiative 2 Joint Undertaking BigData@Heart
Jaap Schouten Foundation
Article History
Received: 21 March 2024
Accepted: 23 June 2024
First Online: 27 June 2024
Competing interests
: I.K. received travel reimbursement from SomaLogic and Olink. J.B. received independent research grant from Abbott for ISS and has had speaker engagement or advisory boards in the past 5 years with Astra Zeneca, Abbott, Boehringer-Ingelheim, Bayer, Daiichi Sankyo, Novartis and Vifor. The remaining authors have no competing interests.